Delivery Order SPE2DB22D9244-SPE2DB24FZS83

Award Date 9/19/24
Potential Completion Date 10/10/24
Potential Value $99K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $19,202.40 and is for the delivery of PRIVIGEN 10% VIAL 200ML, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,173.60 contract is for the supply of PRIVIGEN 10% VIAL 200ML, a pharmaceutical product, with a period of performance through September 19, 2024. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,004.00 award is for the delivery of PRIVIGEN 10% vial, 200 ml, a pharmaceutical product, with a performance period ending on June 4, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,467.00 contract is for the delivery of PRIVIGEN 10% VIAL 100ML, a pharmaceutical product, and has an ultimate completion date of December 13, 2024. The contract is not associated with any set-aside designation. Additionally, DMS Pharmaceutical Group Inc. holds a $499,999,999...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $34,251.00 contract is for the supply of PRIVIGEN 10% VIAL 200ML, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue delivery orders for a wide range of pharmaceutical items...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $58,226.70, is for the delivery of PRIVIGEN 10% VIAL 200ML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. This IDC enables...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,934.00 contract is for the supply of PRIVIGEN 10% vial, a pharmaceutical product, with a period of performance through August 13, 2024. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which allows the DLA...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $27,693.00, is for the delivery of PRIVIGEN 10% VIAL 200ML, a specialized pharmaceutical product. The contract has an ultimate completion date of November 9, 2021 and was awarded on October 19, 2021. DMS Pharmaceutical Group Inc. holds a larger Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,425.12, is for the delivery of PRIVIGEN 10% VIAL 50ML, a pharmaceutical product. The order is part of a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PRIVIGEN 10% VIAL 400ML, a pharmaceutical product, with a ceiling value of $41,101.20 and an ultimate completion date of June 20, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS...
  • SPE2DB22D9244
    Indefinite Delivery Contract
  • SPE2DB22D9244-SPE2DB24FZS83
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $98,802 contract is for the delivery of PRIVIGEN 10% VIAL 200ML, a pharmaceutical product, with an ultimate completion date of October 10, 2024.

The award is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.

Generated 12/19/24, 9:13 AM